전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved665 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleRochePhase 2

atezolizumab (Tecentriq, Atezolizumab - 28 Day Cycle)

Endometrial Cancer · Endometrial Cancer

#EndometrialCancer#Antibody#Phase2#Popular#monoclonal-antibody+2
Trials 53Status Recruiting
AntibodyLimited Datastale3D Medicines (Sichuan) Co., Ltd.Phase 2

Envafolimab (Envafolimab)

Prostate Cancer; CDK12 Gene Mutation · Prostate Cancer

#ProstateCancer#Antibody#Phase2#Popular#monoclonal-antibody+2
Trials 52Status Recruiting
AntibodyCurated CorestaleJanssenPhase 3

Amivantamab (Amivantamab)

Carcinoma, Non-Small-Cell Lung · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#BioJungboMoa-pick#Popular+5
Trials 51Status Recruiting
AntibodyLimited DatastaleRegeneronPhase 2

Cemiplimab REGN2810 (Cemiplimab REGN2810)

Plasma Cell Myeloma · Prostate Cancer

#ProstateCancer#Antibody#Phase2#Popular#monoclonal-antibody+3
Trials 51Status Active
CGTLimited DatastaleAlaunos TherapeuticsPreclinical

autologous activated T lymphocyte (autologous activated T lymphocyte)

Relapsed or Advanced Gastric Adenocarcinoma; Gastro-esophageal Junction Cancer · Relapsed or Advanced Gastric Adenocarcin

#RelapsedorAdvancedGastricAdenoca#CGT#Preclinical#Popular#cell-gene-therapy+5
Trials 51Status Active
AntibodyLimited DatastaleMridula George, MDPhase 2

Retifanlimab (Retifanlimab)

Anatomic Stage IV Breast Cancer AJCC v8; Locally Advanced Breast Carcinoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#Antibody#Phase2#monoclonal-antibody#AnatomicStageIVBreastCancerAJCCv+3
Trials 49Status Recruiting
AntibodyLimited DatastaleChia Tai Tianqing Pharmaceutica…Phase 2

Penpulimab (Penpulimab)

Advanced Malignant Neoplasm · Breast Cancer

#BreastCancer#Antibody#Phase2#monoclonal-antibody#AdvancedMalignantNeoplasm+2
Trials 47Status Active
ADCLimited DatastaleAstellasPhase 3

EV/P (enfortumab vedotin and pembrolizumab, enfortumab vedotin and pembrolizumab (EV/P))

Advanced Bladder Cancer · Advanced Bladder Cancer

#AdvancedBladderCancer#ADC#Phase3#antibody-drug-conjugate#ADCsandimmunotherapyhavechangedt+1
Trials 47Status Recruiting
CGTLimited DatastaleBiohaven Pharmaceuticals, Inc.Phase 3

Autologous cytokine-induced killer cell (Autologous cytokine-induced killer cell)

Small Cell Lung Cancer · Small Cell Lung Cancer

#SmallCellLungCancer#CGT#Phase3#cell-gene-therapy#CAR-T+3
Trials 46Status Active
AntibodyLimited DatastaleGruppo Oncologico del Nord-OvestPhase 2

Balstilimab (Balstilimab)

Colorectal Cancer; Resectable Colorectal Carcinoma · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#ResectableColorectalCarcinoma+1
Trials 45Status Recruiting
CGTLimited DatastaleInnovative Cellular Therapeutic…Phase 2

CART-19 (CART-19)

Hematopoietic/Lymphoid Cancer; Adult Acute Lymphoblastic Leukemia in Remission · B Cell Leukemia

#BCellLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 44Status Active
AntibodyLimited DatastaleHuiKai LiPhase 2

Pucotenlimab (Pucotenlimab)

Biliary Tract Cancer (BTC); EGFR-positive Advanced Biliary Tract Carcinoma · Nasopharyngeal Cancinoma (NPC)

#NasopharyngealCancinomaNPC#Antibody#Phase2#monoclonal-antibody#BiliaryTractCancerBTC+2
Trials 42Status Recruiting
ADCLimited DatastaleMerck Sharp & Dohme LLCDeruxtecan in Patients With…Phase 2

I-DXd (Ifinatamab Deruxtecan, Ifinatamab Deruxtecan (I-DXd))

Carcinoma, Non-Small-Cell Lung · Small-Cell Lung Cancer

#Small-CellLungCancer#ADC#Phase2#antibody-drug-conjugate#Carcinoma+4
Trials 41Status Recruiting
CGTLimited DatastaleOHSU Knight Cancer InstitutePhase 2

Hyper-CVAD (Hyper-CVAD)

Relapsed/Refractory; B-cell Acute Lymphocytic Leukemia · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 40Status Recruiting
CGTLimited DatastaleViroMissile, Inc.Phase 1

oncolytic vaccinia virus (IDOV-Immune, IDOV-Immune (oncolytic vaccinia virus))

Colorectal Cancer; Pancreatic Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 40Status Recruiting
AntibodyLimited DatastaleRegeneron PharmaceuticalsPhase 2

Fianlimab (Fianlimab)

Ovarian Cancer; Fallopian Tube Cancer · NSCLC

#NSCLC#Antibody#Phase2#monoclonal-antibody#OvarianCancer+3
Trials 39Status Recruiting
AntibodyLimited DatastaleGruppo Oncologico del Nord-OvestPhase 2

Botensilimab (Botensilimab)

Colorectal Cancer; Resectable Colorectal Carcinoma · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#ResectableColorectalCarcinoma+1
Trials 38Status Recruiting
AntibodyLimited DatastaleHoffmann-La RochePhase 2

Hu5F9-G4 (Magrolimab, Magrolimab (Hu5F9-G4))

Urothelial Carcinoma; Bladder Cancer · Urothelial Carcinoma

#UrothelialCarcinoma#Antibody#Phase2#monoclonal-antibody#BladderCancer+2
Trials 35Status Active
CGTLimited DatastaleOncolytics BiotechPhase 2

Pelareorep (Pelareorep)

Breast Cancer · Breast Cancer Metastatic

#BreastCancerMetastatic#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 35Status Recruiting
AntibodyLimited DatastaleJazz PharmaceuticalsPhase 2

Zanidatamab (ZW25, ZW25 (Zanidatamab))

HER2+/HR+ Breast Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#HER2++3
Trials 33Status Active

4 / 34 pages

← PreviousNext →